Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Toxicity OF Fluoropyrimidines: A Comparative Study of the Cardiotoxicity of capEcitabine and tEysuno

NCT01845337 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT01845337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01845337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Toxicity OF Fluoropyrimidines: A Comparative Study of the Cardiotoxicity of capEcitabine and tEysuno
Lead sponsor
University of Edinburgh
Phase
Phase 2
Overall status
Completed
Start date
February 5, 2014
Completion date
October 8, 2020
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct neoplasms, cancer of unknown primary site, gastrointestinal cancer, pancreatic cancer